Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Hold
18,500
0.07% 132
2026
Q1
$1.16M Hold
18,500
0.08% 115
2025
Q4
$1.23M Hold
18,500
0.08% 122
2025
Q3
$1.24M Hold
18,500
0.08% 104
2025
Q2
$1.61M Hold
18,500
0.12% 89
2025
Q1
$1.26M Hold
18,500
0.11% 93
2024
Q4
$1.44M Buy
+18,500
New +$1.37M 0.11% 92

Other funds holding DXCM

Triglav Skladi's DXCM Position: Q2 2026 in Review

Triglav Skladi held its DexCom (DXCM) position steady in Q2 2026 at 18,500 shares worth $1.25M. The position accounts for 0.07% of the portfolio, ranked #132.

Triglav Skladi first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.61M in Q2 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Triglav Skladi held 18,500 shares of DexCom worth $1.25M as of Q2 2026.
  • Triglav Skladi left its DexCom share count unchanged in Q2 2026.
  • DexCom made up 0.07% of Triglav Skladi's portfolio in Q2 2026, its #132 holding.
  • Triglav Skladi first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • Triglav Skladi's DexCom position peaked at $1.61M in Q2 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Triglav Skladi's 13F filing for Q2 2026, filed 11 Aug 2026.